Skip to Content

Heska Corp HSKA Stock Quote

| Rating as of


Morningstar‘s Stock Analysis HSKA

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics HSKA

Company Profile HSKA

Business Description

Heska Corp is engaged in developing, manufacturing, marketing, selling & supporting veterinary products. The company's products include Point of Care diagnostic laboratory instruments and consumables; Point of Care digital imaging diagnostic products; reference laboratory testing; digital cytology services; vaccines; local and cloud-based data services; allergy testing and immunotherapy; single-use offerings such as in-clinic diagnostic tests and heartworm preventive products; and practice information management software and related software. It operates through two segments North America and International. The Company's core strategic focus on Point of Care laboratory and imaging products is included in both segments.

3760 Rocky Mountain Avenue
Loveland, CO, 80538
T +1 970 493-7272
Industry Medical Devices
Most Recent Earnings Sep 30, 2022
Fiscal Year End Dec 31, 2022
Employees 655